VCU Health is one of a dozen hospitals nationwide at the forefront of a pivotal clinical trial that could revolutionize ...

Figure 2: Development and noninvasive treatment of bilateral subdural hygromas following placement of a programmable shunt for idiopathic normal pressure hydrocephalus. Although CSF shunting is a ...

CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with normal pressure hydrocephalus (NPH). At the 90-day primary endpoint ...

CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, announced ...

Based on these clinical findings, I plan to pursue further research to facilitate the practical application of ultrasound treatment for patients with normal pressure hydrocephalus.” Lee Dong ...

The classic triad of symptoms gait disturbance, cognitive dysfunction, and urinary incontinence generally responds to treatment if present for less than 2 years' duration. Gait and balance ...

The next step in treating Mr. M was to attempt to determine his responsiveness to ventriculoperitoneal (VP) shunting (Fig 2). Although VP shunting is prone to complications and not appropriate for ...

Background Hydrocephalus is a significant contributor to morbidity following aneurysmal subarachnoid hemorrhage (aSAH). We aimed to investigate the association between primary treatment modality and ...

The hydrocephalus shunt market is experiencing rapid innovation, with newer, more efficient shunt systems being introduced to the market. These advancements are improving patient outcomes and catering ...

Lily Daly died at Children's Health Ireland at Temple Street in Dublin - two weeks ago, her parents settled a legal action at ...

Kolkata: The life of a four-year-old boy suffering from ‘early-onset hydrocephalus' was saved at a city private hospital ...